DNLI
Denali Therapeutics Inc Earnings
$14.52
Earnings Summary
Revenue | $0Mn |
Net Profits | $-124.12Mn |
Net Profit Margins | -Inf% |
Denali Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2025. On a quarterly growth basis, Denali Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Denali Therapeutics Inc’s net profit fell -25.34% since last year same period to $-124.12Mn in the Q2 2025. On a quarterly growth basis, Denali Therapeutics Inc has generated 6.66% jump in its net profits since last 3-months.
Denali Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2025. On a quarterly growth basis, Denali Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.77 |
EPS Estimate Current Year | -0.77 |
Denali Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.77 - a -8.07% fall from last quarter’s estimates.
Denali Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.77.
Key Ratios
Earning Per Share (EPS) | 0 |
Denali Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Denali Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-11 | -0.71 | -0.72 | -1.41% |
2025-10-30 | -0.77 | 0 | 100% |
2025-05-06 | -0.7 | -0.78 | -10.75% |
